A company insider recently sold 20,000 shares of CRISPR Therapeutics AG [CRSP]. Should You also Consider to Sale?
CRISPR Therapeutics AG’s recent filing unveils that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $1.45 million on Mar 15 ’24. In the deal valued at $72.48 per share,20,000 shares were sold. As a result of this transaction, Kulkarni Samarth now holds 208,122 shares worth roughly $14.9 million. Then, Prasad Raju sold […]
Taking a look at what insiders are doing to gauge the CRISPR Therapeutics AG [CRSP]’s direction
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. CRISPR Therapeutics AG shares valued at $1,449,628 were sold by Kulkarni Samarth on Mar 15 ’24. At $72.48 per share, Kulkarni Samarth sold 20,000 shares. The insider’s holdings dropped to 208,122 […]
CRSP (CRISPR Therapeutics AG) may reap gains as insiders became active recently
CRISPR Therapeutics AG’s recent filing unveils that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $0.34 million on Mar 12 ’24. In the deal valued at $74.44 per share,4,583 shares were sold. As a result of this transaction, Kulkarni Samarth now holds 208,122 shares worth roughly $15.18 million. Then, KASINGER JAMES R. […]
CRSP Shares Experience Decline in Value
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. CRISPR Therapeutics AG shares valued at $341,159 were sold by Kulkarni Samarth on Mar 12 ’24. At $74.44 per share, Kulkarni Samarth sold 4,583 shares. The insider’s holdings dropped to 208,122 shares worth approximately […]
The Potential Rise in the Price of CRISPR Therapeutics AG (CRSP) following insiders activity
CRISPR Therapeutics AG’s filing revealed that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $0.51 million on Feb 20 ’24. In the deal valued at $79.67 per share,6,370 shares were sold. As a result of this transaction, Kulkarni Samarth now holds 194,257 shares worth roughly $15.33 million. Then, KASINGER JAMES R. sold […]
A company insider recently sold 6,370 shares of CRISPR Therapeutics AG [CRSP]. Should You Sale?
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. CRISPR Therapeutics AG shares valued at $507,498 were sold by Kulkarni Samarth on Feb 20 ’24. At $79.67 per share, Kulkarni Samarth sold 6,370 shares. The insider’s holdings dropped to 194,257 shares worth approximately […]
CRISPR Therapeutics AG [CRSP] Insider Kulkarni Samarth sells 6,370 Shares – Insider Selling Alert
CRISPR Therapeutics AG’s filing revealed that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $0.51 million on Feb 20. In the deal valued at $79.67 per share,6,370 shares were sold. As a result of this transaction, Kulkarni Samarth now holds 194,257 shares worth roughly $16.27 million. Then, KASINGER JAMES R. sold 1,913 […]
CRSP short interest fall by -14.59%, reflecting positive sentiment
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. CRISPR Therapeutics AG shares valued at $507,498 were sold by Kulkarni Samarth on Feb 20. At $79.67 per share, Kulkarni Samarth sold 6,370 shares. The insider’s holdings dropped to 194,257 shares worth approximately $17.03 […]
CRISPR Therapeutics AG [CRSP] Insider Kulkarni Samarth sells 6,370 Shares
CRISPR Therapeutics AG’s recently made public that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $0.51 million on Feb 20. In the deal valued at $79.67 per share,6,370 shares were sold. As a result of this transaction, Kulkarni Samarth now holds 194,257 shares worth roughly $16.32 million. Then, KASINGER JAMES R. sold […]
Insider Kulkarni Samarth sells 20,000 of CRISPR Therapeutics AG [CRSP] Stock
CRISPR Therapeutics AG’s recent filing unveils that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $1.61 million on Feb 15. In the deal valued at $80.36 per share,20,000 shares were sold. As a result of this transaction, Kulkarni Samarth now holds 187,377 shares worth roughly $14.75 million. Then, Kulkarni Samarth sold 50,000 […]